Navigation Links
Boston Scientific Announces Favorable Appellate Court Ruling Affirming Non-Infringement of Johnson & Johnson Patent
Date:9/28/2011

tions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements.  These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release.  As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.  

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and future business decisions made by us and our competitors.  All of these factors are difficult or impossible to predict accurately and many of them are beyond our control.  For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A – Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A – Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file hereafter.  We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.  This cautionary statement is applicable to all forward-looking statements contained in this document.CONTACT:

Denise Kaigler508-650-8330 (office)Media RelationsBos
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... American Association of Diabetes Educators, American Diabetes ... A. Menarini, Bayer Group, Bayer Healthcare, BioTex, ... Medicare and Medicaid Services ( USA ... Prevention (CDC), Carlyle Group, Cascade Metrix Inc., ... ConvaTec, Constitution Medical Investor, Dexcom, Diabetes UK, ...
(Date:3/1/2015)... 2015  An innovative interventional radiology treatment has ... relief of their headaches, according to research being ... ,s Annual Scientific Meeting . Clinicians at ... York Empire State College in Saratoga Springs used ... blocks to give patients enough ongoing relief that ...
(Date:2/27/2015)... , Feb. 27, 2015 Roughly ... or very confident substituting an interchangeable biosimilar for ... share the same nonproprietary name, according to a ... Pharmacy,s (AMCP,s) Journal of Managed Care & ... about 25 percent of pharmacists would feel as ...
Breaking Medicine Technology:Blood Glucose Meters Industry 2019 Forecasts for Global and Chinese Regions 2Image-guided treatment shown to break the migraine cycle 2Image-guided treatment shown to break the migraine cycle 3Image-guided treatment shown to break the migraine cycle 4Survey Published in AMCP's JMCP Finds Pharmacists Are Most Confident Substituting Interchangeable Biosimilars for Brand Biologics When Products Share Nonproprietary Name 2
... , PISCATAWAY, N.J., Dec. 1 ... of hearing instruments, announced its third annual partnership with Quota ... September 2010. , As part of the renewed partnership, Siemens ... hearing instruments to both children and young adults, age 23 ...
... , ... Board: CBPO) (Nasdaq: CBPO ) ("China Biologic," or,the "Company"), one ... Company has received approval to list its,common stock on the NASDAQ ... shares to begin trading on the NASDAQ on,Wednesday, December 2, 2009, ...
Cached Medicine Technology:Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 2Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 3China Biologic Products Approved to List on NASDAQ 2China Biologic Products Approved to List on NASDAQ 3
(Date:3/2/2015)... The Alliance for Bangladesh Worker Safety today ... to serve as chief safety officer. In this role, ... Bangladesh and guide remediation efforts in all factories from ... that the Alliance continues to bring world-class expertise to ... workers,” said Alliance Independent Chair Ellen Tauscher. “His role ...
(Date:3/2/2015)... Viejo, California (PRWEB) March 02, 2015 ... release of the TranStatic Volume 2 from Pixel Film Studios. ... transitions made exclusively for FCPX,” said Christina Austin, CEO of ... to have in any Final Cut Pro X editors toolbox.” ... scene to the next with media altering static scrambling effects ...
(Date:3/1/2015)... 02, 2015 As residents and ... co-founders, Michael Burns and Carita Weaver, believe in ... working with the Southlake Chamber of Commerce, Carroll ... works recently launched a website for Southlake mayoral ... primary communications tool for Hill’s campaign, the website ...
(Date:3/1/2015)... NY (PRWEB) March 01, 2015 Adults ... seek insurance rates for term or universal policies can ... some of the best life insurance companies for single ... the system at http://quotespros.com/life-insurance.html . , The rate ... search portal are tied to a number of life ...
(Date:3/1/2015)... The number of transvaginal mesh lawsuits ( ... weeks in two New Jersey litigations where attorneys at ... announces. , A Case List updated on February ... proceeding established for products manufactured by Johnson & Johnson's ... when 90 fewer cases had been centralized. Additionally, 1,700 ...
Breaking Medicine News(10 mins):Health News:Alliance for Bangladesh Worker Safety Names New Chief Safety Officer 2Health News:Pixel Film Studios released the TranStatic Volume 2 plugin for Final Cut Pro X today 2Health News:Website Launched for Southlake, Texas Mayoral Candidate Laura Hill 2Health News:Best Life Insurance Companies for Single Adults Now Searchable at Insurance Website 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 3Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 4
... lacosamide, developed by U.S firm Schwarz has found to be ... controlled by other drugs - the company said on Monday ... ,The results of the 485-patient study were presented at the ... treated with a 200-mg dose of the drug, lacosamide, had ...
... Study finds that adolescence boys are at higher risk for ... have found that the seeds of hypertension and its health ... lack of exercise, obesity are some of the factors for ... heart damages. ,In the study which began in ...
... can affect children as young as seven years old to ... restricted to// young women alone. ,Anorexia Nervosa is ... the behavior of binging and vomiting. Bulimia is two to ... that can prove to be lethal. ,Anorexic at ...
... blames inappropriate advertising to be the cause of most ... bans and restrictions on// advertising to teens and children. ... Doctor and the lead author of the guidelines, says ... on television alone and increasingly are being exposed to ...
... coordinator, explained how India’s legal stance on homosexuality is actually ... an// infringement of the human rights of homosexual men. ... to book, in cases dealing with sexual abuse of children. ... it may cause a setback to nailing those who commit ...
... World Bank has prepared a report in which it says, a ... is required to fight bird flu in the next 2 to ... at a conference to be held in the West African country ... poultry farmers caught in the front line should be effectively compensated. ...
Cached Medicine News:Health News:Teen Boys At Greater Risk To High Blood Pressure Than Girls 2Health News:From Six to Sixty, Everyone is Prone to Anorexia 2Health News:Extra Funding To Fight Bird Flu 2
... TBR-40 is a small bench style refrigerator (can ... only a minimum number of bags is to ... External cabinet finish is white colorbond steel while ... closing side hinged glass door is key lockable. ...
... refrigerator is specially designed ... blood in standard 500ml ... Standard AS3864 1997. Quiet ... utilising CFC Free refrigerant ...
The Testosterone Enzyme Immunoassay is intended for the quantitative determination of Testosterone concentration in human serum. No special pretreatment of the sample is necessary. For in vitro Diag...
The Testosterone ELISA is intended for the quantitative determination of testosterone concentration in human serum. No special pretreatment of the sample is necessary....
Medicine Products: